APO RESEARCH · REPORT
Rosuvastatin Calcium
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Product & engineering
Understand the product.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
Selected research
Market Outlook & Growth Opportunities
Global Rosuvastatin Calcium Market Outlook and Growth Opportunities 2026
Market perspective
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
In additional, EU is also the largest consumer of rosuvastatin calcium, about 34% of the global production was consumed in EU. China is the second producer with the market share of 28%. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55% of the total amount.
Read the full market overview
This report provides an overview of the global Rosuvastatin Calcium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Rosuvastatin Calcium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Rosuvastatin Calcium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rosuvastatin Calcium market size, projected growth trends, production technologies, key applications, and end-use industries.
Rosuvastatin Calcium Segment by Company
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Rosuvastatin Calcium Segment by Type
Purity 98.0%
Purity 99.0%
Other
Rosuvastatin Calcium Segment by Application
Tablet (including dispersible tablet and general tablet)
Capsule
Others
Rosuvastatin Calcium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Rosuvastatin Calcium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Rosuvastatin Calcium market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Rosuvastatin Calcium significant trends, drivers, influence factors in global and regions.
6. To analyze Rosuvastatin Calcium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin Calcium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Rosuvastatin Calcium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rosuvastatin Calcium industry.
Chapter 3: Detailed analysis of Rosuvastatin Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Rosuvastatin Calcium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Rosuvastatin Calcium in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 98.0%
- Purity 99.0%
- Other
Applications
- Tablet (including dispersible tablet and general tablet)
- Capsule
- Others
Companies covered
- AstraZeneca
- Teva Pharmaceutical Industries
- MSN Laboratories
- Cadila Pharmaceuticals
- LGM Pharma
- Bal Pharma
- Changzhou Pharmaceutical Factory
- Jingxin Pharm
- Zhejiang Hisun Pharmaceutical
- HEC Pharm
- Lunan Pharmaceutical
- Nanjing Frochem Tech
- Lianyungang Runzhong Pharmaceutical
- Shandong Bechem Chemicals
- CTX Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Rosuvastatin Calcium Sales Value (2021-2032)
- 1.2.2 Global Rosuvastatin Calcium Sales Volume (2021-2032)
- 1.2.3 Global Rosuvastatin Calcium Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Rosuvastatin Calcium Market Dynamics
- 2.1 Rosuvastatin Calcium Industry Trends
- 2.2 Rosuvastatin Calcium Industry Drivers
- 2.3 Rosuvastatin Calcium Industry Opportunities and Challenges
- 2.4 Rosuvastatin Calcium Industry Restraints
3 Rosuvastatin Calcium Market by Company
- 3.1 Global Rosuvastatin Calcium Company Revenue Ranking in 2025
- 3.2 Global Rosuvastatin Calcium Revenue by Company (2021-2026)
- 3.3 Global Rosuvastatin Calcium Sales Volume by Company (2021-2026)
- 3.4 Global Rosuvastatin Calcium Average Price by Company (2021-2026)
- 3.5 Global Rosuvastatin Calcium Company Ranking (2024-2026)
- 3.6 Global Rosuvastatin Calcium Company Manufacturing Base and Headquarters
- 3.7 Global Rosuvastatin Calcium Company Product Type and Application
- 3.8 Global Rosuvastatin Calcium Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Rosuvastatin Calcium Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Rosuvastatin Calcium Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Rosuvastatin Calcium Market by Type
- 4.1 Rosuvastatin Calcium Type Introduction
- 4.1.1 Purity 98.0%
- 4.1.2 Purity 99.0%
- 4.1.3 Other
- 4.2 Global Rosuvastatin Calcium Sales Volume by Type
- 4.2.1 Global Rosuvastatin Calcium Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Rosuvastatin Calcium Sales Volume by Type (2021-2032)
- 4.2.3 Global Rosuvastatin Calcium Sales Volume Share by Type (2021-2032)
- 4.3 Global Rosuvastatin Calcium Sales Value by Type
- 4.3.1 Global Rosuvastatin Calcium Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Rosuvastatin Calcium Sales Value by Type (2021-2032)
- 4.3.3 Global Rosuvastatin Calcium Sales Value Share by Type (2021-2032)
5 Rosuvastatin Calcium Market by Application
- 5.1 Rosuvastatin Calcium Application Introduction
- 5.1.1 Tablet (including dispersible tablet and general tablet)
- 5.1.2 Capsule
- 5.1.3 Others
- 5.2 Global Rosuvastatin Calcium Sales Volume by Application
- 5.2.1 Global Rosuvastatin Calcium Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Rosuvastatin Calcium Sales Volume by Application (2021-2032)
- 5.2.3 Global Rosuvastatin Calcium Sales Volume Share by Application (2021-2032)
- 5.3 Global Rosuvastatin Calcium Sales Value by Application
- 5.3.1 Global Rosuvastatin Calcium Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Rosuvastatin Calcium Sales Value by Application (2021-2032)
- 5.3.3 Global Rosuvastatin Calcium Sales Value Share by Application (2021-2032)
6 Rosuvastatin Calcium Regional Sales and Value Analysis
- 6.1 Global Rosuvastatin Calcium Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Rosuvastatin Calcium Sales by Region (2021-2032)
- 6.2.1 Global Rosuvastatin Calcium Sales by Region: 2021-2026
- 6.2.2 Global Rosuvastatin Calcium Sales by Region (2027-2032)
- 6.3 Global Rosuvastatin Calcium Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Rosuvastatin Calcium Sales Value by Region (2021-2032)
- 6.4.1 Global Rosuvastatin Calcium Sales Value by Region: 2021-2026
- 6.4.2 Global Rosuvastatin Calcium Sales Value by Region (2027-2032)
- 6.5 Global Rosuvastatin Calcium Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Rosuvastatin Calcium Sales Value (2021-2032)
- 6.6.2 North America Rosuvastatin Calcium Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Rosuvastatin Calcium Sales Value (2021-2032)
- 6.7.2 Europe Rosuvastatin Calcium Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Rosuvastatin Calcium Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Rosuvastatin Calcium Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Rosuvastatin Calcium Sales Value (2021-2032)
- 6.9.2 South America Rosuvastatin Calcium Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Rosuvastatin Calcium Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Rosuvastatin Calcium Sales Value Share by Country, 2025 VS 2032
7 Rosuvastatin Calcium Country-level Sales and Value Analysis
- 7.1 Global Rosuvastatin Calcium Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Rosuvastatin Calcium Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Rosuvastatin Calcium Sales by Country (2021-2032)
- 7.3.1 Global Rosuvastatin Calcium Sales by Country (2021-2026)
- 7.3.2 Global Rosuvastatin Calcium Sales by Country (2027-2032)
- 7.4 Global Rosuvastatin Calcium Sales Value by Country (2021-2032)
- 7.4.1 Global Rosuvastatin Calcium Sales Value by Country (2021-2026)
- 7.4.2 Global Rosuvastatin Calcium Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.9.2 France Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.16.2 China Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.19.2 India Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Rosuvastatin Calcium Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Rosuvastatin Calcium Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Rosuvastatin Calcium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 AstraZeneca
- 8.1.1 AstraZeneca Company Information
- 8.1.2 AstraZeneca Business Overview
- 8.1.3 AstraZeneca Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.1.4 AstraZeneca Rosuvastatin Calcium Product Portfolio
- 8.1.5 AstraZeneca Recent Developments
- 8.2 Teva Pharmaceutical Industries
- 8.2.1 Teva Pharmaceutical Industries Company Information
- 8.2.2 Teva Pharmaceutical Industries Business Overview
- 8.2.3 Teva Pharmaceutical Industries Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Teva Pharmaceutical Industries Rosuvastatin Calcium Product Portfolio
- 8.2.5 Teva Pharmaceutical Industries Recent Developments
- 8.3 MSN Laboratories
- 8.3.1 MSN Laboratories Company Information
- 8.3.2 MSN Laboratories Business Overview
- 8.3.3 MSN Laboratories Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.3.4 MSN Laboratories Rosuvastatin Calcium Product Portfolio
- 8.3.5 MSN Laboratories Recent Developments
- 8.4 Cadila Pharmaceuticals
- 8.4.1 Cadila Pharmaceuticals Company Information
- 8.4.2 Cadila Pharmaceuticals Business Overview
- 8.4.3 Cadila Pharmaceuticals Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Cadila Pharmaceuticals Rosuvastatin Calcium Product Portfolio
- 8.4.5 Cadila Pharmaceuticals Recent Developments
- 8.5 LGM Pharma
- 8.5.1 LGM Pharma Company Information
- 8.5.2 LGM Pharma Business Overview
- 8.5.3 LGM Pharma Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.5.4 LGM Pharma Rosuvastatin Calcium Product Portfolio
- 8.5.5 LGM Pharma Recent Developments
- 8.6 Bal Pharma
- 8.6.1 Bal Pharma Company Information
- 8.6.2 Bal Pharma Business Overview
- 8.6.3 Bal Pharma Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Bal Pharma Rosuvastatin Calcium Product Portfolio
- 8.6.5 Bal Pharma Recent Developments
- 8.7 Changzhou Pharmaceutical Factory
- 8.7.1 Changzhou Pharmaceutical Factory Company Information
- 8.7.2 Changzhou Pharmaceutical Factory Business Overview
- 8.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Product Portfolio
- 8.7.5 Changzhou Pharmaceutical Factory Recent Developments
- 8.8 Jingxin Pharm
- 8.8.1 Jingxin Pharm Company Information
- 8.8.2 Jingxin Pharm Business Overview
- 8.8.3 Jingxin Pharm Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Jingxin Pharm Rosuvastatin Calcium Product Portfolio
- 8.8.5 Jingxin Pharm Recent Developments
- 8.9 Zhejiang Hisun Pharmaceutical
- 8.9.1 Zhejiang Hisun Pharmaceutical Company Information
- 8.9.2 Zhejiang Hisun Pharmaceutical Business Overview
- 8.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Product Portfolio
- 8.9.5 Zhejiang Hisun Pharmaceutical Recent Developments
- 8.10 HEC Pharm
- 8.10.1 HEC Pharm Company Information
- 8.10.2 HEC Pharm Business Overview
- 8.10.3 HEC Pharm Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.10.4 HEC Pharm Rosuvastatin Calcium Product Portfolio
- 8.10.5 HEC Pharm Recent Developments
- 8.11 Lunan Pharmaceutical
- 8.11.1 Lunan Pharmaceutical Company Information
- 8.11.2 Lunan Pharmaceutical Business Overview
- 8.11.3 Lunan Pharmaceutical Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Lunan Pharmaceutical Rosuvastatin Calcium Product Portfolio
- 8.11.5 Lunan Pharmaceutical Recent Developments
- 8.12 Nanjing Frochem Tech
- 8.12.1 Nanjing Frochem Tech Company Information
- 8.12.2 Nanjing Frochem Tech Business Overview
- 8.12.3 Nanjing Frochem Tech Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Nanjing Frochem Tech Rosuvastatin Calcium Product Portfolio
- 8.12.5 Nanjing Frochem Tech Recent Developments
- 8.13 Lianyungang Runzhong Pharmaceutical
- 8.13.1 Lianyungang Runzhong Pharmaceutical Company Information
- 8.13.2 Lianyungang Runzhong Pharmaceutical Business Overview
- 8.13.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Lianyungang Runzhong Pharmaceutical Rosuvastatin Calcium Product Portfolio
- 8.13.5 Lianyungang Runzhong Pharmaceutical Recent Developments
- 8.14 Shandong Bechem Chemicals
- 8.14.1 Shandong Bechem Chemicals Company Information
- 8.14.2 Shandong Bechem Chemicals Business Overview
- 8.14.3 Shandong Bechem Chemicals Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Shandong Bechem Chemicals Rosuvastatin Calcium Product Portfolio
- 8.14.5 Shandong Bechem Chemicals Recent Developments
- 8.15 CTX Life Sciences
- 8.15.1 CTX Life Sciences Company Information
- 8.15.2 CTX Life Sciences Business Overview
- 8.15.3 CTX Life Sciences Rosuvastatin Calcium Sales, Value and Gross Margin (2021-2026)
- 8.15.4 CTX Life Sciences Rosuvastatin Calcium Product Portfolio
- 8.15.5 CTX Life Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Rosuvastatin Calcium Value Chain Analysis
- 9.1.1 Rosuvastatin Calcium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Rosuvastatin Calcium Sales Mode & Process
- 9.2 Rosuvastatin Calcium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Rosuvastatin Calcium Distributors
- 9.2.3 Rosuvastatin Calcium Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst